November 21, 2011 (New York, New York) — Three-year follow-up of the RESILIENT trial has shown that the LifeStent vascular stent (Bard Peripheral Vascular) leads to durable benefits and clinical ...
Please provide your email address to receive an email when new articles are posted on . Endovascular therapy, compared with surgery, was associated with significantly lower perioperative morbidity and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results